Literature DB >> 26827727

A Stable Mutant Predisposes Antibody Domains to Amyloid Formation through Specific Non-Native Interactions.

Cardine N Nokwe1, Manuel Hora2, Martin Zacharias3, Hisashi Yagi4, Jirka Peschek1, Bernd Reif2, Yuji Goto4, Johannes Buchner5.   

Abstract

The aggregation of mostly antibody light chain variable (VL) domains into amyloid fibrils in various tissues is the main cause of death in systemic amyloid light chain amyloidosis. Point mutations within the domain are important to shift the VL into the fibrillar pathway, but why and how only some site-specific mutations achieve this still remains elusive. We show here that both destabilizing and surprisingly stable mutants readily predispose an amyloid-resistant VL domain to amyloid formation. The decreased thermodynamic stability of the destabilizing mutant results in the accumulation of non-native intermediates that readily populate the amyloid state. Interestingly, the stable mutants establish site-specific non-native interactions with especially nearby serine/threonine residues that unexpectedly do not affect the folding behavior of the VL domain but rather readily induce and stabilize the fibril structure, a previously unrecognized mechanism. These findings provide a new concept for the molecular mechanism of amyloid fibril formation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antibody amyloid; domain stability; immunoglobulin fold; point mutations; protein folding and aggregation disease

Mesh:

Substances:

Year:  2016        PMID: 26827727     DOI: 10.1016/j.jmb.2016.01.015

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation.

Authors:  Daniele Peterle; Elena S Klimtchuk; Thomas E Wales; Florian Georgescauld; Lawreen H Connors; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2021-10-19       Impact factor: 5.469

2.  Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.

Authors:  Pamina Kazman; Marie-Theres Vielberg; María Daniela Pulido Cendales; Lioba Hunziger; Benedikt Weber; Ute Hegenbart; Martin Zacharias; Rolf Köhler; Stefan Schönland; Michael Groll; Johannes Buchner
Journal:  Elife       Date:  2020-03-10       Impact factor: 8.140

3.  A single residue switch reveals principles of antibody domain integrity.

Authors:  Benedikt Weber; Matthias J Brandl; María Daniela Pulido Cendales; Carolin Berner; Tejaswini Pradhan; Gina Maria Feind; Martin Zacharias; Bernd Reif; Johannes Buchner
Journal:  J Biol Chem       Date:  2018-09-18       Impact factor: 5.157

4.  Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: A combined NMR and in silico study.

Authors:  Sujoy Mukherjee; Simon P Pondaven; Kieran Hand; Jillian Madine; Christopher P Jaroniec
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

5.  MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.

Authors:  Manuel Hora; Riddhiman Sarkar; Vanessa Morris; Kai Xue; Elke Prade; Emma Harding; Johannes Buchner; Bernd Reif
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

6.  Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains.

Authors:  Manuel Hora; Martin Carballo-Pacheco; Benedikt Weber; Vanessa K Morris; Antje Wittkopf; Johannes Buchner; Birgit Strodel; Bernd Reif
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

7.  Determinants of the assembly and function of antibody variable domains.

Authors:  Eva Maria Herold; Christine John; Benedikt Weber; Stephan Kremser; Jonathan Eras; Carolin Berner; Sabrina Deubler; Martin Zacharias; Johannes Buchner
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

8.  Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.

Authors:  Lynn Radamaker; Yin-Hsi Lin; Karthikeyan Annamalai; Stefanie Huhn; Ute Hegenbart; Stefan O Schönland; Günter Fritz; Matthias Schmidt; Marcus Fändrich
Journal:  Nat Commun       Date:  2019-03-20       Impact factor: 14.919

9.  Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability.

Authors:  Tejaswini Pradhan; Karthikeyan Annamalai; Riddhiman Sarkar; Stefanie Huhn; Ute Hegenbart; Stefan Schönland; Marcus Fändrich; Bernd Reif
Journal:  J Biol Chem       Date:  2020-10-22       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.